Literature DB >> 15135365

Potential applications and prospects for cardiac xenotransplantation.

Kiyoshi Ogata1, Jeffrey L Platt.   

Abstract

Despite improvements in pharmacologic therapies, the outlook for patients with severe cardiac disease remains poor. At present, the only "cure" for end-stage heart failure is transplantation. However, fewer than 5% of those who need a cardiac transplant receive one in the United States each year. As an alternative, some propose using animals as a source of organs for transplantation (i.e., xenotransplantation). In this article we review the potential applications of xenotransplantation for the treatment of cardiac disease, and weigh xenotransplantation against other new technologies that might be used. We also consider the current status of addressing the hurdles to application of xenotransplantation.

Entities:  

Mesh:

Year:  2004        PMID: 15135365     DOI: 10.1016/j.healun.2003.07.007

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  6 in total

1.  Correction of hemophilia as a proof of concept for treatment of monogenic diseases by fetal spleen transplantation.

Authors:  Anna Aronovich; Dalit Tchorsh; Helena Katchman; Smadar Eventov-Friedman; Elias Shezen; Uri Martinowitz; Bruce R Blazar; Sivan Cohen; Orna Tal; Yair Reisner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-05       Impact factor: 11.205

2.  CD4 T cells mediate cardiac xenograft rejection via host MHC Class II.

Authors:  Robert J Plenter; Todd J Grazia; An N Doan; Ronald G Gill; Biagio A Pietra
Journal:  J Heart Lung Transplant       Date:  2012-07-11       Impact factor: 10.247

3.  Managing drugs and devices in patients with permanent ventricular assist devices.

Authors:  Martin Cadeiras; Manuel von Bayern; Mario C Deng
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

4.  The management of mechanical hearts.

Authors:  Gilbert H Mudge
Journal:  Trans Am Clin Climatol Assoc       Date:  2005

5.  Embryonic pig pancreatic tissue transplantation for the treatment of diabetes.

Authors:  Smadar Eventov-Friedman; Dalit Tchorsh; Helena Katchman; Elias Shezen; Anna Aronovich; Gil Hecht; Benjamin Dekel; Gideon Rechavi; Bruce R Blazar; Ilan Feine; Orna Tal; Enrique Freud; Yair Reisner
Journal:  PLoS Med       Date:  2006-07       Impact factor: 11.069

6.  Leflunomide Inhibits rat-to-Mouse Cardiac Xenograft Rejection by Suppressing Adaptive Immune Cell Response and NF-κB Signaling Activation.

Authors:  Yunhan Ma; Baiyi Xie; Junjun Guo; Yingyu Chen; Mengya Zhong; Qingru Lin; Jianyu Hua; Jiaying Zhong; Xuewei Luo; Guoliang Yan; Helong Dai; Zhongquan Qi
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.